The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Gene Review

Ctl1  -  cytotoxic T lymphocyte response 1

Mus musculus

Synonyms: Ctl-1
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Ctl1


High impact information on Ctl1


Chemical compound and disease context of Ctl1


Biological context of Ctl1


Anatomical context of Ctl1


Associations of Ctl1 with chemical compounds


Physical interactions of Ctl1


Regulatory relationships of Ctl1


Other interactions of Ctl1


Analytical, diagnostic and therapeutic context of Ctl1


  1. Cytotoxic T lymphocyte response to murine cytomegalovirus infection. Quinnan, G.V., Manischewitz, J.E., Ennis, F.A. Nature (1978) [Pubmed]
  2. Junctional biases in the naive TCR repertoire control the CTL response to an immunodominant determinant of HSV-1. Wallace, M.E., Bryden, M., Cose, S.C., Coles, R.M., Schumacher, T.N., Brooks, A., Carbone, F.R. Immunity (2000) [Pubmed]
  3. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. Ahmed, R., Salmi, A., Butler, L.D., Chiller, J.M., Oldstone, M.B. J. Exp. Med. (1984) [Pubmed]
  4. Autoimmune diabetes can be induced in transgenic major histocompatibility complex class II-deficient mice. Laufer, T.M., von Herrath, M.G., Grusby, M.J., Oldstone, M.B., Glimcher, L.H. J. Exp. Med. (1993) [Pubmed]
  5. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101. Sredni, B., Tichler, T., Shani, A., Catane, R., Kaufman, B., Strassmann, G., Albeck, M., Kalechman, Y. J. Natl. Cancer Inst. (1996) [Pubmed]
  6. Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo. Haurum, J.S., Høier, I.B., Arsequell, G., Neisig, A., Valencia, G., Zeuthen, J., Neefjes, J., Elliott, T. J. Exp. Med. (1999) [Pubmed]
  7. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. Bennett, S.R., Carbone, F.R., Karamalis, F., Miller, J.F., Heath, W.R. J. Exp. Med. (1997) [Pubmed]
  8. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. Blachere, N.E., Li, Z., Chandawarkar, R.Y., Suto, R., Jaikaria, N.S., Basu, S., Udono, H., Srivastava, P.K. J. Exp. Med. (1997) [Pubmed]
  9. Recurrent T cell receptor rearrangements in the cytotoxic T lymphocyte response in vivo against the p815 murine tumor. Levraud, J.P., Pannetier, C., Langlade-Demoyen, P., Brichard, V., Kourilsky, P. J. Exp. Med. (1996) [Pubmed]
  10. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. Nahill, S.R., Welsh, R.M. J. Exp. Med. (1993) [Pubmed]
  11. An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo. Loudon, R.P., Moraska, A.F., Huber, S.A., Schwimmbeck, P., Schultheiss, P. J. Virol. (1991) [Pubmed]
  12. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. Vitiello, A., Marchesini, D., Furze, J., Sherman, L.A., Chesnut, R.W. J. Exp. Med. (1991) [Pubmed]
  13. Cytotoxic T lymphocyte response to minor H-43a alloantigen in H-43b mice. Privileged H-2Kb restriction to the response is not due to immunodominance or epistatic effect but due to Ir gene function of H-2Kb itself. Hino, T., Ishikawa, H., Saito, K. J. Immunol. (1988) [Pubmed]
  14. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Razvi, E.S., Jiang, Z., Woda, B.A., Welsh, R.M. Am. J. Pathol. (1995) [Pubmed]
  15. Ir gene control of the cytotoxic T lymphocyte response to Sendai virus: H-2k mice are low responders to Sendai. Shapiro, M.E., Burakoff, S.J., Benacerraf, B., Finberg, R.W. J. Immunol. (1981) [Pubmed]
  16. Genetically encoded and post-translationally modified forms of a major histocompatibility complex class I-restricted antigen bearing a glycosylation motif are independently processed and co-presented to cytotoxic T lymphocytes. Hudrisier, D., Riond, J., Mazarguil, H., Oldstone, M.B., Gairin, J.E. J. Biol. Chem. (1999) [Pubmed]
  17. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Wiktor, T.J., Macfarlan, R.I., Reagan, K.J., Dietzschold, B., Curtis, P.J., Wunner, W.H., Kieny, M.P., Lathe, R., Lecocq, J.P., Mackett, M. Proc. Natl. Acad. Sci. U.S.A. (1984) [Pubmed]
  18. Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-alpha/beta. Sandberg, K., Kemper, P., Stalder, A., Zhang, J., Hobbs, M.V., Whitton, J.L., Campbell, I.L. J. Immunol. (1994) [Pubmed]
  19. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells. Kast, W.M., Boog, C.J., Roep, B.O., Voordouw, A.C., Melief, C.J. J. Immunol. (1988) [Pubmed]
  20. Antipeptide antibody specific for the N-terminal of soluble immune response suppressor neutralizes concanavalin A and IFN-induced suppressor cell activity in an in vitro cytotoxic T lymphocyte response. Devens, B.H., Semenuk, G., Webb, D.R. J. Immunol. (1988) [Pubmed]
  21. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors. Schmid, D.S., Rouse, B.T. J. Immunol. (1983) [Pubmed]
  22. Rescue of anti-influenza A virus cytotoxic T-lymphocyte responses in chemotherapy-suppressed mice. Merluzzi, V.J., Welte, K., Mertelsmann, R.H., Souza, L., Boone, T., Last-Barney, K. J. Virol. (1984) [Pubmed]
  23. Characterization of the culture filtrate-specific cytotoxic T lymphocyte response induced by Bacillus Calmette-Guérin vaccination in H-2b mice. Denis, O., Huygen, K. Int. Immunol. (1999) [Pubmed]
  24. Polychlorinated biphenyl-induced immune suppression: castration, but not adrenalectomy or RU 38486 treatment, partially restores the suppressed cytotoxic T lymphocyte response to alloantigen. De Krey, G.K., Baecher-Steppan, L., Deyo, J.A., Smith, B., Kerkvliet, N.I. J. Pharmacol. Exp. Ther. (1993) [Pubmed]
  25. Effect of in vitro exposure to styrene, styrene oxide, and other structurally related compounds on murine cell-mediated immunity. Grayson, M.H., Gill, S.S. Immunopharmacology (1986) [Pubmed]
  26. Histamine augments interleukin-2 production and the activation of cytotoxic T lymphocytes. Dröge, W., Schmidt, H., Nick, S., Sonsky, B. Immunopharmacology (1986) [Pubmed]
  27. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection. Mieno, M., Suto, R., Obata, Y., Udono, H., Takahashi, T., Shiku, H., Nakayama, E. J. Exp. Med. (1991) [Pubmed]
  28. The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2. Peacock, C.D., Lin, M.Y., Ortaldo, J.R., Welsh, R.M. J. Virol. (2000) [Pubmed]
  29. Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection. Gaddum, R.M., Cook, R.S., Wyld, S.G., López, J.A., Bustos, R., Melero, J.A., Taylor, G. J. Gen. Virol. (1996) [Pubmed]
  30. Ultraviolet-light-inactivated Cas-Br-M murine leukemia virus induces a protective CD8+ cytotoxic T lymphocyte response in newborn mice. Sarzotti, M., Dean, T.A., Remington, M., Hoffman, P.M. AIDS Res. Hum. Retroviruses (1994) [Pubmed]
  31. In vivo analysis of adenovirus-specific cytotoxic T lymphocyte response in mice deficient in CD28, fas ligand, and perforin. Chen, J., Hsu, H.C., Zajac, A.J., Wu, Q., Yang, P., Xu, X., McPherson, S.A., Li, J., Curiel, D.T., Mountz, J.D. Hum. Gene Ther. (2006) [Pubmed]
  32. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. Bukreyev, A., Belyakov, I.M., Prince, G.A., Yim, K.C., Harris, K.K., Berzofsky, J.A., Collins, P.L. J. Virol. (2005) [Pubmed]
  33. Treatment with anti-LFA-1 delays the CD8+ cytotoxic-T-lymphocyte response and viral clearance in mice with primary respiratory syncytial virus infection. Rutigliano, J.A., Johnson, T.R., Hollinger, T.N., Fischer, J.E., Aung, S., Graham, B.S. J. Virol. (2004) [Pubmed]
  34. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. Whitmire, J.K., Slifka, M.K., Grewal, I.S., Flavell, R.A., Ahmed, R. J. Virol. (1996) [Pubmed]
  35. Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease. Qu, B., Rosenberg, R.N., Li, L., Boyer, P.J., Johnston, S.A. Arch. Neurol. (2004) [Pubmed]
  36. Acquisition by the murine host of responsiveness toward various neoplastic cell lines, but not toward self, through adoptive transfer of a helper T-lymphocyte clone with antiself specificity. Grooten, J., Fiers, W. Cancer Res. (1989) [Pubmed]
  37. In vivo functional clonal deletion of recipient CD4+ T helper precursor cells that can recognize class II MHC on injected donor lymphoid cells. Kiziroglu, F., Miller, R.G. J. Immunol. (1991) [Pubmed]
  38. Gene transfer to the thymus. A means of abrogating the immune response to recombinant adenovirus. DeMatteo, R.P., Raper, S.E., Ahn, M., Fisher, K.J., Burke, C., Radu, A., Widera, G., Claytor, B.R., Barker, C.F., Markmann, J.F. Ann. Surg. (1995) [Pubmed]
  39. Broadened clinical utility of gene gun-mediated, granulocyte-macrophage colony-stimulating factor cDNA-based tumor cell vaccines as demonstrated with a mouse myeloma model. Turner, J.G., Tan, J., Crucian, B.E., Sullivan, D.M., Ballester, O.F., Dalton, W.S., Yang, N.S., Burkholder, J.K., Yu, H. Hum. Gene Ther. (1998) [Pubmed]
  40. Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine. Rodolfo, M., Zilocchi, C., Cappetti, B., Parmiani, G., Melani, C., Colombo, M.P. Gene Ther. (1999) [Pubmed]
WikiGenes - Universities